Search for a funded project
Explorez notre base de projets financés
COVID 19 Rapid diagnosis test (development and clinical validation in 7 weeks) – CORaDiag
an acute respiratory disease caused by novel coronavirus SARS-CoV-2 also known as 2019-nCoV. On March
Role of SARS-CoV-2-infected pulmonary cells and antibody response in COVID-19 outcomes: From pathophysiology to testing candidate drugs in mucosal cell models – MUCOLUNG
Syndrome)-CoV (Corona virus)-2 is a novel airborne coronavirus threatening public health that is currently spreading
Trust in science and public institutions challenged by Covid-19 – CIESCO
government officials and scientists during the coronavirus crisis. The instructions to contain the epidemic [...] , in a region that was less affected by the Coronavirus. The qualitative investigation will also aim
Viral dynamics at the individual and population levels: impact for antiviral treatment optimization – TheraCoV
outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originat-ed in Wuhan, China
Umbilical cord-derived mesenchymal stromal cells therapy in SARS-CoV-2-related ARDS – STROMA-CoV2
spread, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Severe Acute Respiratory
Household transmission investigation study for SARS-CoV-2 in French Guiana – EPI-COVID-19
Since December 2019, a new coronavirus, SARS-CoV-2, has been identified in the city of Wuhan in China
Prospective analysis of morbi-mortality of patients with cancers in active phase of medical treatment suspected or diagnosed of a SARS-COV2 infection. – ONCOVID-19
Since December 2019, the novel coronavirus (SRAS-COV2, causing an emerging infectious disease called [...] clinical outcome of patients with a suspected coronavirus infection (either confirmed or not) while receiving
Pull the COVID-19 replicative catalytic core apart – PullCoVapart
multi-protein replication complexes. The genome of coronaviruses (CoV) is a positive-sense, single-stranded RNA
Inborn errors of immunity underlying life-threatening COVID-19 in previously healthy patients – GENCOVID
In December 2019, a pneumonia due to a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, China [...] ranging from asymptomatic infection to lethal coronavirus infectious disease-19 (COVID-19). Two groups
Engineering nanobinders to block SARS-CoV-2 entry – SARS2BlockEntry
The novel coronavirus SARS-CoV-2 has recently emerged as a human pathogen in China’s Hubei province, [...] high-titer neutralizing antibodies in others coronaviruses and to fold independently from other spike domains